Studying the effectiveness of probing as initial treatment in adult patients with symptoms of nasolacrimal duct obstruction referred to the ophthalmology clinic of Sina Hospital. Other disorders of lacrimal gland
Conditions
Interventions
Intervention 1: Intervention group: This group includes patients who undergo probing as initial treatment. Intervention 2: Control group: This group includes patients who resort to other treatment met
Sponsors
Hamedan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients with nasolacrimal duct obstruction Duration of symptoms and tearing in patients less than one year
Exclusion criteria
Exclusion criteria: History of previous trauma to the eye Previous history of lacrimal duct surgery (DCR)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tear secretions return from the duct. Timepoint: Immediately after probing: For immediate review and assessment of treatment success in the same session.A few days later: To assess the improvement and durability of the probing effect.A few weeks or months later: To assess the long-term effectiveness of the treatment. Method of measurement: Clinical examination: By a doctor, checking for tear secretions in the nasolacrimal duct and observing whether the secretions drain naturally. This involves examining the patient's eyes and tear ducts and recording the presence or absence of secretions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Retreatment of nasolacrimal duct obstruction. Timepoint: Usually at intervals of 1, 3, and 6 months after the initial treatment. Method of measurement: Clinical examination and imaging: Examination of the duct after a specified period of time, using methods such as imaging scans to reassess the obstruction. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaeda Bahrami
Hamedan University of Medical Sciences
Outcome results
None listed